Awaiting trials success, UK seals early access to 3 Covid-19 vaccine candidates

The three vaccine classes that the Boris Johnson government has secured through partnerships are: adenoviral vaccines (University of Oxford/AstraZeneca); mRNA vaccines (BioNTech/Pfizer, Imperial College London) and the inactivated whole virus vaccines (Valneva).

from Hindustan Times - world https://ift.tt/30seUEt